Worked with pharmaceutical industry lobbyists on passage of 1988 process patent amendments, assisting in meetings with congressional staff and drafting report language regarding what constitutes a "material change" for purposes of determining liability when products are modified prior to importation.
){kind=logo}
Email has been submitted successfully. Thanks!
Error sending the email. Please try again later.